Medrifar en es it fr

Medrifar Brand names, Medrifar Analogs

Medrifar Brand Names Mixture

  • No information avaliable

Medrifar Chemical_Formula

C17H25N3O5S

Medrifar RX_link

http://www.rxlist.com/cgi/generic2/meropen.htm

Medrifar fda sheet

Medrifar FDA

Medrifar msds (material safety sheet)

Medrifar Synthesis Reference

No information avaliable

Medrifar Molecular Weight

383.464 g/mol

Medrifar Melting Point

No information avaliable

Medrifar H2O Solubility

Sparingly

Medrifar State

Solid

Medrifar LogP

0.33

Medrifar Dosage Forms

Powder for solution (for injection)

Medrifar Indication

For use as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms: complicated skin and skin structure infections due to Staphylococcus aureus (b-lactamase and non-b-lactamase producing, methicillin-susceptible isolates only), Streptococcus pyogenes, Streptococcus agalactiae, viridans group streptococci, Enterococcus faecalis (excluding vancomycin-resistant isolates), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis and Peptostreptococcus species; complicated appendicitis and peritonitis caused by viridans group streptococci, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacteroides fragilis, B. thetaiotaomicron, and Peptostreptococcus species. Also for use in the treatment of bacterial meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (b-lactamase and non-b-lactamase-producing isolates), and Neisseria meningitidis.

Medrifar Pharmacology

Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death.

Medrifar Absorption

No information avaliable

Medrifar side effects and Toxicity

In mice and rats, large intravenous doses of meropenem (2200-4000 mg/kg) have been associated with ataxia, dyspnea, convulsions, and mortalities.

Medrifar Patient Information

Medrifar Organisms Affected

Enteric bacteria and other eubacteria